Economic Evaluation of Diphtheria, Tetanus, and Acellular Pertussis (DTaP) Vaccine in the United States: A Cost-Benefit and Cost-Effectiveness Model with Visual Basic Application | Zendy

AI Assistant Blog Pricing

Economic Evaluation of Diphtheria, Tetanus, and Acellular Pertussis (DTaP) Vaccine in the United States: A Cost-Benefit and Cost-Effectiveness Model with Visual Basic Application

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.